Goldman Sachs
IH

Goldman Sachs’s iHuman IH Stock Holding History

Goldman Sachs’s Portfolio IH Stock Details IH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46,030
Closed -$129K – 6716
2021
Q4 		$129K Buy
+46,030
New +$198K ﹤0.01% 6061

Other funds holding IH

APA
Arisaig Partners (Asia) Singapore $2.17M AUM 37.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs's IH Position: Q1 2022 in Review

Goldman Sachs sold out of iHuman (IH) in Q1 2022, closing a stake of 46,030 shares — an estimated $129K sold.

Goldman Sachs first reported a position in IH in Q4 2021 and held it in 1 quarter. The position peaked at $129K in Q4 2021. 6 funds tracked by Wall St. Rank hold IH as of Q1 2022.

  • Goldman Sachs reported no remaining iHuman position as of Q1 2022 after selling out during the quarter.
  • Goldman Sachs sold 46,030 iHuman shares in Q1 2022, an estimated $129K.
  • Goldman Sachs first reported a position in iHuman in Q4 2021 and held it in 1 quarter.
  • Goldman Sachs's iHuman position peaked at $129K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held iHuman as of Q1 2022.

Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.